Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Nicotine Patch Not Beneficial in Parkinson's

    Nicotine Patch Not Beneficial in Parkinson's

    A recent MJFF-supported study found that nicotine patches do not slow progression in people with early, untreated Parkinson's disease.
    Learn more

  • Patients and Providers Report Experiences with Rytary

    Patients and Providers Report Experiences with Rytary

    An MJFF survey evaluated patients' and clinicians' perspectives on and experiences with Rytary in the "real world," outside of clinical trials.
    Learn more

  • A Duet with Dystonia

    A Duet with Dystonia

    Dystonia can be a symptom of Parkinson's or a complication of treatment. It can also be a disease by itself, affecting up to two percent of professional musicians.
    Learn more

  • What We Fund: $6 Million in New Grants for Parkinson’s Research

    What We Fund: $6 Million in New Grants for Parkinson’s Research

    MJFF announces 41 new grant awards to better understand, measure, and treat Parkinson’s disease, as well as develop new research tools.
    Learn more

  • News in Context: FDA "Breakthrough Therapy Designation" and Acadia's Nuplazid

    News in Context: FDA "Breakthrough Therapy Designation" and Acadia's Nuplazid

    The designation applies to drugs that have shown an effect on a serious condition or symptom in early clinical data.
    Learn more

  • Therapy for Movement Symptoms Shows Positive Results in Parkinson's Model

    Therapy for Movement Symptoms Shows Positive Results in Parkinson's Model

    A study funded by The Michael J. Fox Foundation shows a new treatment improved tremor, slowness and mobility problems in Parkinson's models.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.